Xu T - Search Results

1

Optimization of CRISPR-Cas system for clinical cancer therapy.

Meng X, Wu TG, Lou QY, Niu KY, Jiang L, Xiao QZ, Xu T, Zhang L. Meng X, et al. Among authors: xu t. Bioeng Transl Med. 2022 Dec 23;8(2):e10474. doi: 10.1002/btm2.10474. eCollection 2023 Mar. Bioeng Transl Med. 2022. PMID: 36925702 Free PMC article. Review.

2

The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases.

Wu YC, Yao Y, Tao LS, Wang SX, Hu Y, Li LY, Hu S, Meng X, Yang DS, Li H, Xu T. Wu YC, et al. Among authors: xu t. Cell Signal. 2023 Feb;102:110550. doi: 10.1016/j.cellsig.2022.110550. Epub 2022 Dec 1. Cell Signal. 2023. PMID: 36464104 Review.

3

The role of interleukin-20 in liver disease: Functions, mechanisms and clinical applications.

Wang K, Zhan HQ, Hu Y, Yuan ZY, Yang JF, Yang DS, Tao LS, Xu T. Wang K, et al. Among authors: xu t. Heliyon. 2024 Apr 17;10(9):e29853. doi: 10.1016/j.heliyon.2024.e29853. eCollection 2024 May 15. Heliyon. 2024. PMID: 38699038 Free PMC article. Review.

4

Recent advances of Phosphodiesterase 4B in cancer.

Miao Y, Peng L, Chen Z, Hu Y, Tao L, Yao Y, Wu Y, Yang D, Xu T. Miao Y, et al. Among authors: xu t. Expert Opin Ther Targets. 2023 Feb;27(2):121-132. doi: 10.1080/14728222.2023.2183496. Epub 2023 Feb 28. Expert Opin Ther Targets. 2023. PMID: 36803246 Review.

5

The Role and Therapeutic Potential of Non-coding RNAs in Resistance to EGFR-TKIs targeted therapy for Non-small Cell Lung Cancer.

Zhang Y, Chen Y, Lu LL, Xie XL, Huan R, Wu LF, Tan LN, Xu T, Jin Y. Zhang Y, et al. Among authors: xu t. Curr Med Chem. 2024 Feb 16. doi: 10.2174/0109298673275752231219080500. Online ahead of print. Curr Med Chem. 2024. PMID: 38375847

6

CD73/NT5E-mediated ubiquitination of AURKA regulates alcohol-related liver fibrosis via modulating hepatic stellate cell senescence.

Liu Z, Wu B, Liu X, Wu X, Du J, Xia G, Cai J, Zhu H, Sheng X, Zhang M, Xu J, Xu T, Lv X. Liu Z, et al. Among authors: xu t, xu j. Int J Biol Sci. 2023 Jan 16;19(3):950-966. doi: 10.7150/ijbs.80461. eCollection 2023. Int J Biol Sci. 2023. PMID: 36778123 Free PMC article.

7

Non-thermal plasma-treated melatonin inhibits the biological activity of HCC cells by increasing intracellular ROS levels and reducing RRM2 expression.

Chen B, Jin T, Fu Z, Li H, Yang J, Liu Y, Han Y, Wang X, Wu Z, Xu T. Chen B, et al. Among authors: xu t. Heliyon. 2023 May 3;9(5):e15992. doi: 10.1016/j.heliyon.2023.e15992. eCollection 2023 May. Heliyon. 2023. PMID: 37215864 Free PMC article.

8

Puerarin inhibits inflammation and lipid accumulation in alcoholic liver disease through regulating MMP8.

Hu Y, Wang S, Wu L, Yang K, Yang F, Yang J, Hu S, Yao Y, Xia X, Liu Y, Peng L, Wan J, Shen C, Xu T. Hu Y, et al. Among authors: xu t. Chin J Nat Med. 2023 Sep;21(9):670-681. doi: 10.1016/S1875-5364(23)60399-1. Chin J Nat Med. 2023. PMID: 37777317

9

The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential.

Hu SZ, Yuan ZY, Zhang XX, Yu XJ, Ni HY, Sun SJ, Xu T, Zhan HQ. Hu SZ, et al. Among authors: xu t. J Autoimmun. 2024 Dec;149:103329. doi: 10.1016/j.jaut.2024.103329. Epub 2024 Nov 5. J Autoimmun. 2024. PMID: 39504927 Review.

10

Quaternary Ammonium Salts: Insights into Synthesis and New Directions in Antibacterial Applications.

Zhou Z, Zhou S, Zhang X, Zeng S, Xu Y, Nie W, Zhou Y, Xu T, Chen P. Zhou Z, et al. Among authors: xu t, xu y. Bioconjug Chem. 2023 Feb 15;34(2):302-325. doi: 10.1021/acs.bioconjchem.2c00598. Epub 2023 Feb 7. Bioconjug Chem. 2023. PMID: 36748912 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,198 results

Search Page

Filters